Eminent clinical study: it was reported that the subject experienced a dissection, requiring an additional stent.Baseline rutherford classification was performed on the subject which revealed category 2 moderate claudication.Baseline angiography analysis of the right distal superficial femoral artery (sfa) involving the proximal popliteal artery (ppa) revealed no calcification, with absence of thrombus, ulceration, or aneurysm.Inflow tract patency (stenosis less than 50%) was observed.The subject therefore underwent treatment with these 6x80x130 and 6x60x130 innova stents as part of the eminent clinical trial.The 90% stenosed target lesion was located in the right distal sfa involving the ppa and was 60mm long with a proximal reference vessel diameter of 6mm and distal reference vessel diameter of 6mm and was classified as transatlantic intersociety consensus (tasc) ii b lesion.During the procedure, pre-dilation of the target lesion was performed followed by placement of the 6mm x 60mm study stent.A subsequent dissection occurred in the distal sfa post stent placement.Therefore, an additional 6mm x 80mm study stent was placed.Following post-dilation, the residual stenosis was 5%.The subject was discharged with antiplatelet therapy.
|